United Community Banks, Inc. UCB NYSE · Financials · United States
$37.33 +0.16% +$0.06
Summary
43 / 100 · Bulios Score
What speaks for it
- Revenue grew by 18% a year over the last 3 years.
- It has raised its dividend 5 years in a row.
- It bought back its own shares for $135.8M in the last fiscal year, 3.0% of its market value.
What to watch
- The share price is above the Bulios Fair Price.
- 82% of profit goes to the dividend, leaving little room to raise it.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBy our assumptions the business is worth less than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 30.4 USD for 1 USD of yearly profit. Over the last five years it was 14.0 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 17% a year over 5 years. Over the last 3 years it grew by 18% a year. Earnings per share grew by 1.3% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 34 USD
- Sales and administration 52 USD
- Taxes and other 2.3 USD
- Net profit 12 USD
Net profit, industry median (Banks - Regional) 21 USD
Out of every 100 USD of revenue, 12 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, stretched- Yield
- 2.71%
- Paid out of profit
- 82%
- Raised in a row
- 5 years
You receive $1.01 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 3
- Hold 4
- Sell 0
Today's price within the analysts' price targets
The average target of $40.33 is 8.0% above today's price. 43% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.